CurePSP, the leading research and advocacy nonprofit organization for PSP, CBD and MSA, has elected F. Jackson (Jack) Phillips as the next Chair of the nonprofit's Board of Directors. Phillips will work closely with CurePSP's executive director and chief science officer, Kristophe Diaz, PhD, and the Board, to advance CurePSP's mission and strategic objectives.
Frontotemporal Dementia Management MarketThe global Frontotemporal Dementia Management Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Frontotemporal.
/PRNewswire/ CurePSP has awarded its latest Pathway and Pipeline Grants and Urso Student Fellowships, totaling over $422,000. Recipients of the grants are:.
The global Frontotemporal Disorders Treatment Market is anticipated to reach US$ 451.4 million by the end of 2028, according to the company’s most recent research. The frontotemporal disorders therapy market has a sizable growth potential, with an average annual growth rate of 4.7% through 2028, according to the ana.
/PRNewswire/ CurePSP, a leading not-for-profit organization dedicated to advancing patient support and treatments of rare neurodegenerative diseases, is.